Login / Signup

A review of promoting access to medicines in China - problems and recommendations.

Jing SunCecile Jia HuMark StuntzHans HogerzeilYuanli Liu
Published in: BMC health services research (2018)
The complicated and interdependent problems interact in a way that leads to significant system problems in China, which create dual challenges that both the developing country and the developed countries are facing. To further promote access to medicines, China should speed up the re-assessment of the quality and efficacy of domestically produced generic medicines; coordinate various reforms of price determination, insurance payments, and procurement policies; address medicine shortages through comprehensive policies and legislation; establish specific mechanisms to achieve sustainable equitable access to expensive essential medicines with health technology assessment as a tool to ensure that policy and priority setting are created in a coherent and evidence-based way.
Keyphrases
  • mental health
  • public health
  • healthcare
  • health insurance
  • health information
  • clinical practice
  • climate change
  • molecularly imprinted
  • high resolution
  • health promotion
  • affordable care act